Immunotherapy in Gynecologic Cancers: Current Evidence, Biomarker-Driven Practice, and Future Directions
Simple Summary Immunotherapy has changed the treatment of several gynecologic cancers, but its benefit varies greatly between tumor types and clinical settings. The clearest benefits are seen when treatment is matched to tumor biology, such as mismatch repair deficiency in endometrial cancer or PD-L1 expression in sele...